📢 Don't miss the exclusive interview with DrCaliff_FDA, conducted by drjohnwhyte! They discuss vital topics: misinformation, drug shortages, marijuana regulation, obesity, and AI in drug review. Tune in! MedNews Healthcare
I think it's always good to have in the back of your mind that harm can be done. I've lived my whole career, as you know, working with people developing new treatments. And if you're excited about the treatment, you may not see the downside. It's just in my nature to think about the potential downside, but I'm very excited about the upside.
Do you expect there perhaps to be a difference as we're starting to see greater attention in terms of obesity?You bring up a really interesting area that we are all going to need to do more work on. As you know, we regulate the pharmaceutical companies; we don't regulate doctors, we don't regulate the practice of medicine. And this is actually related to the Adderall issue that we were describing.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
‘Exciting Time’: FDA Commissioner Talks AI and MisinformationShould we be worried about AI's growing influence in healthcare, and what can the FDA do about the Adderall shortage? WebMD Chief Medical Officer drjohnwhyte sat down with US_FDA Commissioner Dr. Robert M. Califf to talk about this and more. Watch here:
Leer más »
Former DPS superintendent Susana Cordova poised to become Colorado’s next education commissionerThe Colorado Board of Education announced Tuesday that it has selected Susana Cordova, the former superintendent of Denver Public Schools, to become the state’s next commissioner of education.
Leer más »
Former DPS Superintendent Susana Cordova selected as Colorado Commissioner of EducationThe former superintendent of Denver Public Schools is taking on a new roll. Susana Cordova was selected to be the next Colorado Commissioner of Education.
Leer más »
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNNThe US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Leer más »
When courts challenge the FDA’s authority, they put patients’ lives at riskThe entire biotechnology and pharmaceutical industry will be thrown into turmoil if judges can second-guess the scientific expertise of the US Food and Drug Administration.
Leer más »
FDA warns about compounded versions of popular weight loss drugsFederal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
Leer más »